-
-
-
-
-
-
-
Emergent BioSolutions Reports Third Quarter 2025 Financial Results
-
-
-
-
-
-
-
Emergent BioSolutions Reports Third Quarter 2024 Financial Results
-
-
-
-
-
-
-
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
-
-
-
-
-
-
-
Bavarian Nordic Completes Acquisition of Travel Vaccine Portfolio from Emergent BioSolutions
-
-
-
-
-
-
-
Emergent BioSolutions Announces Sale of Travel Health Business to Bavarian Nordic for Up To $380 Million
-
-
-
-
-
-
-
Emergent BioSolutions Receives Department of Defense Award to Evaluate Chikungunya Vaccine Candidate in Post-Approval Field Efficacy Study Using Model-Guided Approach
-
-
-
-
-
-
-
Pre-Open Stock Movers 05/16: ManTech, WideOpenWest Gain on M&A; Chimerix Plunges on TEMBEXA Deal (more...)
-
1,157,596 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

